Details for New Drug Application (NDA): 012715
✉ Email this page to a colleague
NDA 012715 describes GANTANOL-DS, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the GANTANOL-DS profile page.
The generic ingredient in GANTANOL-DS is sulfamethoxazole. There are twenty-seven drug master file entries for this compound. Additional details are available on the sulfamethoxazole profile page.
The generic ingredient in GANTANOL-DS is sulfamethoxazole. There are twenty-seven drug master file entries for this compound. Additional details are available on the sulfamethoxazole profile page.
Summary for 012715
| Tradename: | GANTANOL-DS |
| Applicant: | Roche |
| Ingredient: | sulfamethoxazole |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012715
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1GM | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
